Managed Healthcare
@mhexecutive
Helping managed care executives succeed every day.
ID: 55591433
10-07-2009 15:37:25
16,16K Tweet
3,3K Followers
466 Following
Results from a phase 2a study suggest that the benefits of Tezspire (tezepelumab) for people with chronic pulmonary obstructive disease may be limited to those with elevated blood eosinophil counts indicative of type 2 inflammation. #ATS2024 managedhealthcareexecutive.com/view/tezspire-…